1. From the Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA; the Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA; and the Novartis Institutes for Biomedical Research, CH-4002 Basel, Switzerland.